RTTNews | Dec 9, 2020 07:17AM EST

07:17 Wednesday, December 9, 2020 (RTTNews) - REGENXBIO Announces Positive Interim Data And Update For Phase I/II Trial Of RGX-121 For Mucopolysaccharidosis Type II

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved